awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38708145-39561747-6BBF-45F8-AD37-1170C73A29D3
Q38708145-39561747-6BBF-45F8-AD37-1170C73A29D3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38708145-39561747-6BBF-45F8-AD37-1170C73A29D3
Developing drugs for use before, during and soon after percutaneous coronary intervention.
P2860
Q38708145-39561747-6BBF-45F8-AD37-1170C73A29D3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38708145-39561747-6BBF-45F8-AD37-1170C73A29D3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
681cc5d4651ecf7a5931c11c0bc3a95319c31705
P2860
ISAR-REACT 3A: a study of reduced dose of unfractionated heparin in biomarker negative patients undergoing percutaneous coronary intervention.